Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.
about
Lysophosphatidic acid and apolipoprotein A1 predict increased risk of developing World Trade Center-lung injury: a nested case-control studyStructural insights into the oligomerization mode of the human receptor for advanced glycation end-productsStable RAGE-Heparan Sulfate Complexes Are Essential for Signal TransductionThe Bulk of Autotaxin Activity Is Dispensable for Adult Mouse LifeThe multiple faces of RAGE--opportunities for therapeutic intervention in aging and chronic diseasePlasma Soluble Receptor for Advanced Glycation End Products in Idiopathic Pulmonary Fibrosis.Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles.RAGE regulates the metabolic and inflammatory response to high-fat feeding in miceLysophosphatidic acid acts as a nutrient-derived developmental cue to regulate early hematopoiesis.Source and role of intestinally derived lysophosphatidic acid in dyslipidemia and atherosclerosis.Lysophospholipid mediators in the vasculatureEvaluation of 11C-acetate and 18F-FDG PET/CT in mouse multidrug resistance gene-2 deficient mouse model of hepatocellular carcinoma.Soluble RAGEs - Prospects for treating & tracking metabolic and inflammatory diseaseEmerging Targets for Therapeutic Development in Diabetes and Its Complications: The RAGE Signaling Pathway.S100A12 and the S100/Calgranulins: Emerging Biomarkers for Atherosclerosis and Possibly Therapeutic Targets.Enzymatically Modified Low-Density Lipoprotein Promotes Foam Cell Formation in Smooth Muscle Cells via Macropinocytosis and Enhances Receptor-Mediated Uptake of Oxidized Low-Density Lipoprotein.Radical roles for RAGE in the pathogenesis of oxidative stress in cardiovascular diseases and beyond.The autotaxin-LPA axis emerges as a novel regulator of lymphocyte homing and inflammation.Arguing the case for the autotaxin-lysophosphatidic acid-lipid phosphate phosphatase 3-signaling nexus in the development and complications of atherosclerosis.RAGE regulation and signaling in inflammation and beyond.Molecular strategies to prevent, inhibit, and degrade advanced glycoxidation and advanced lipoxidation end products.Unlocking the biology of RAGE in diabetic microvascular complicationsEffect of diet-derived advanced glycation end products on inflammation.Lysophospholipids and Their Receptors Serve as Conditional DAMPs and DAMP Receptors in Tissue Oxidative and Inflammatory Injury.2016 ATVB Plenary Lecture: Receptor for Advanced Glycation Endproducts and Implications for the Pathogenesis an Treatment of Cardiometabolic Disorders: Spotlight on the Macrophage.Lysophosphatidic acid activates the RhoA and NF-κB through Akt/IκBα signaling and promotes prostate cancer invasion and progression by enhancing functional invadopodia formation.Lysophosphatidic acid and cardiovascular disease: seeing is believing.Change in the Molecular Dimension of a RAGE-Ligand Complex Triggers RAGE Signaling.Receptor for advanced glycation end-products and World Trade Center particulate induced lung function loss: a case-cohort study and murine model of acute particulate exposureAge dependent accumulation patterns of advanced glycation end product receptor (RAGE) ligands and binding intensities between RAGE and its ligands differ in the liver, kidney, and skeletal muscle.Expression and purification of the extracellular domains of human glycoprotein VI (GPVI) and the receptor for advanced glycation end products (RAGE) from Rattus norvegicus in Leishmania tarentolae.Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation.Autotaxin in Pathophysiology and Pulmonary Fibrosis.
P2860
Q23915586-787BD0DD-AD8D-45D6-B4B8-E006ACBFDF91Q24338271-4D388279-2C95-458D-BD52-9EFADCF0057CQ27678167-9AB2A7F2-54F3-4C8C-8F73-DE3C6DC32C74Q28550987-31C59950-11C2-4A6C-AA40-289FF989ED84Q28830568-1899F897-35F4-4506-B07C-4D089D2A2089Q30253065-2ACED02E-AE6A-46F8-8741-FF53B20337ADQ30407920-E232F2DB-D9F4-409E-A144-7B506ACEE9A3Q33646761-BABC4E63-9F1E-4A20-8D8F-88EBD8A13AB4Q34324614-4F75CB27-2C05-4B8C-A287-9247E1E1E2BEQ35217048-86BF5755-7C8E-43F9-99A7-D190D33B27AAQ35533485-45C04E48-A157-4FE4-9D75-0E4179C78154Q35633633-87CBFA87-9936-4455-9CC0-9258F723BE73Q35991574-9ABD9735-48F4-47B0-BD4A-AADA9AE249E1Q36207823-868318C1-CA1D-4CB0-9D85-E12C17050191Q36631781-13816744-6AE1-41F2-B947-1D618A3732A3Q36940618-0D3790DD-8821-41C6-A713-DBF1CBF7F0A6Q37291206-CFB33027-64DD-4BDC-9251-0D1EED0363B9Q37527792-30D8F413-5C93-4676-99C6-09343DE75362Q37620329-83B5002E-3213-4D87-8000-F0EC87348608Q38094691-9613623E-D4CC-448D-8A20-2E716425A64DQ38096444-6CDF2DFE-2970-4C2D-BA60-B68C8EA5BD9FQ38134924-DDC3A38F-58F1-459D-B940-C91E157E5392Q38588208-32C1331C-9D2F-4502-B258-F6D70AD9E2A3Q38742072-44E5CE28-D804-4BC8-8B0E-FA344483C870Q38759194-401CD939-F850-47AA-8BCA-B4434E67A5C6Q38812074-7B66F013-7C81-44BB-98C7-5E7587710765Q39741379-6B38D0CC-7410-47BC-B6F2-D95989303951Q41036883-0420856F-6D9E-4863-9A3D-81B108A72535Q41571383-0BBC271E-7FB7-4C51-807C-9AEEF8DF1776Q41993914-1443742F-DE12-4DF4-A25D-E196B02428B1Q47877902-6CB83A02-8A05-4950-B925-40F3C1A45AB7Q52689639-6092F24B-1E8A-4F91-B698-DA9239FA611AQ55420502-69D11C4E-5E1D-4557-B4B7-23EEB05BDC8E
P2860
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.
@ast
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.
@en
type
label
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.
@ast
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.
@en
prefLabel
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.
@ast
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.
@en
P2093
P2860
P356
P1476
Lysophosphatidic acid targets vascular and oncogenic pathways via RAGE signaling.
@en
P2093
Ann Marie Schmidt
Fatouma Touré
Jinghua Zhang
Ravichandran Ramasamy
Renjun Pei
Rosa Rosario
Seth Chitayat
P2860
P304
P356
10.1084/JEM.20120873
P407
P577
2012-12-03T00:00:00Z